Background: Anticoagulants are the class of drugs that are used to prevent thrombus extension and embolic complications by reducing the rate of fibrin formation. They do not dissolve already formed clot but prevent recurrences. Method: A total of 200 patients were included in these prospective, uni-centric, observational studies who were suffering from Cardiovascular Diseases, from the cardiology inpatient department at a tertiary care hospital in Bangalore. Results: It was observed that out of 200 patients included in the study, 122 (61%) patients were treated with anticoagulants and antiplatelets, 75(37.5%) were treated with anticoagulants only. Out of 200 prescriptions encountered, 198 (99%) prescriptions have rational use of anticoagula...
Objective: To study patients receiving anticoagulants with or without antiplatelet therapy presentin...
ABSTRACT Introduction: Drug utilization evaluation of anticoagulant drugs is essential considering t...
Background Bleeding is the most serious complication of the use of oral anticoagulation in the preve...
Cilj: Cilj ovog diplomskog rada bio je ispitati utjecaj primjene antikoagulantnih lijekova na klinič...
Background: Common risk factors for gastrointestinal bleeding (GIB) are advanced age and the use of ...
New oral anticoagulants are effective for the prevention of thromboembolic complications in pati...
Background/Aims: There are a limited number of studies including the impact of antiplatelet drugs us...
Objectives: Warfarin-induced bleedingresults in increased morbidity and mortality and higher cost of...
In Norway, antithrombotic drugs have been the drugs most often reported to the Norwegian spontaneous...
Introduction: Antithrombotic agents, which include antiplatelet agents and anticoagulants, are incre...
Drug utilization (DU) is systematic regulatory approach designed to identify diversity of drugs use ...
International audienceIntroduction: The gastrointestinal (GI) tract is a frequent site of bleeding i...
Objective: To study patients receiving anticoagulants with or without antiplatelet therapy presentin...
ABSTRACT Introduction: Drug utilization evaluation of anticoagulant drugs is essential considering t...
Background Bleeding is the most serious complication of the use of oral anticoagulation in the preve...
Cilj: Cilj ovog diplomskog rada bio je ispitati utjecaj primjene antikoagulantnih lijekova na klinič...
Background: Common risk factors for gastrointestinal bleeding (GIB) are advanced age and the use of ...
New oral anticoagulants are effective for the prevention of thromboembolic complications in pati...
Background/Aims: There are a limited number of studies including the impact of antiplatelet drugs us...
Objectives: Warfarin-induced bleedingresults in increased morbidity and mortality and higher cost of...
In Norway, antithrombotic drugs have been the drugs most often reported to the Norwegian spontaneous...
Introduction: Antithrombotic agents, which include antiplatelet agents and anticoagulants, are incre...
Drug utilization (DU) is systematic regulatory approach designed to identify diversity of drugs use ...
International audienceIntroduction: The gastrointestinal (GI) tract is a frequent site of bleeding i...
Objective: To study patients receiving anticoagulants with or without antiplatelet therapy presentin...
ABSTRACT Introduction: Drug utilization evaluation of anticoagulant drugs is essential considering t...
Background Bleeding is the most serious complication of the use of oral anticoagulation in the preve...